云南白药 (000538)

YUNNAN BAIYAO GROUP CO.,LTD.

ASZ

Tags

300ESG Index300 Non-Cyclical IndexMSCI Component StocksCSI 100 IndexCSI 200 IndexCSI A100 IndexAnalyst Recommended StocksNorthbound Heavy PositionsMedical Aesthetics ConceptFace Mask ProtectionState-Owned Enterprise ReformGuozheng Value IndexLarge Cap ValueLarge Cap StocksCCTV 50 IndexInvestment ClockBackdoor ListingsHigh-Performing StocksIndustry LeadersBidding TargetsChina Securities Finance and Central Huijin HoldingsTongdaxin 88Non-Cyclical StocksHigh-Dividend StocksHigh Accounts ReceivableShenzhen Main Board 50 IndexShenzhen ConnectSZSE 100 IndexSZSE 300 IndexSZSE Value IndexSZSE Governance IndexCSFC HoldingsPharma & BiotechChinese Med. IISZSE Defensive 50 IndexStable Growth IndexConsumer Services IndexSZSE Medicine Equal Weight IndexBrand Engineering IndexSZSE Clock IndexSZSE 100 Equal Weight IndexYangtze River Protection IndexCSI Emerging Industries IndexJuchao Large-cap IndexShenzhen A-Share Pharmaceutical IndexBOC International CSI 300 ESG IndexJuchao 100 IndexCSI 100 Low Volatility IndexCSI All-share Pharmaceutical Sector IndexCSI 800 Dividend Low Volatility IndexSZSE Emerging Industries IndexCSI 300 Dividend Low Volatility IndexSZSE 1000 IndexSZSE 300 Return IndexCSSW Health IndexSZSE Component Index ReturnCSI 300 Equal Weight IndexCSI 300 ESG IndexLarge & Mid-cap IndexShanghai-Hong Kong-Shenzhen 300 IndexCNI 1000 IndexXingyin Wealth Management Balanced 300 IndexSZSE Fundamental 60 IndexCR Foundation IndexCSSW Silk Road IndexOrient Securities Value IndexInfluenza/MaskRestructuringConvertible Bond IssuersLocal State-owned Assets ReformPrivate PlacementMSCISecurities Firms Heavy HoldingsHuijin ConceptShareholding Increase CommitmentLarge-cap Blue-chipInsurance Heavy HoldingsVenture CapitalCSI 300 Non-cyclical IndexCNI Emerging Industries IndexPension Industry IndexSZSE Selected IndexSZSE Responsibility IndexCNI Culture IndexCSI 300 Shenzhen Market IndexCCTV Growth IndexSZSE Technology IndexSZSE Leaders IndexCCTV Culture IndexEmerging Industries Composite IndexSZSE 100 Return IndexManufacturing IndexSZSE ChiNext 100 IndexSecurities Times Value 100 IndexSZSE Pharmaceutical IndexCSI 800 IndexCS Pharmaceutical TI Index100 Performance IndexCSI 300 Preferred IndexCNI Pharmaceutical IndexCSI 1000 Pharmaceutical IndexCNI 300 IndexCCTV 500 IndexCSI 300 USD (CNH) IndexHua Xia Bank ESG IndexA500 Dividend Low Volatility IndexSZSE Component Pharmaceutical IndexPharmaceutical Sub-sector IndexSZSE Low Volatility IndexCSI All-share Pharmaceutical IndexCSI 300 USD IndexSZSE Pharmaceutical 50 IndexSZSE 300 Equal Weight IndexCSI Pharmaceutical IndexZhaoyang 100 IndexCSI 800 Pharmaceutical IndexSZSE Component Index Equal WeightPharmaceutical & Health 100 IndexCSI 300 Value Stable IndexCSI 300 Pharmaceutical IndexCSI 300 Pharmaceutical IndexHigh Dividend Yield Strategy IndexCSI 700 IndexAH Economic Blue-chip IndexSZSE Fundamental 200 IndexFundamental 200 IndexPharmaceutical 50 Strategy IndexYangtze River 100 IndexCICC 300 IndexESG 300 IndexCR New Momentum IndexChina Economic Index GDPCSI 1000 Value IndexSZSE Fundamental 120 IndexFundamental 600 IndexStrategic Emerging Industries 100 Index

K-Line Chart

No K-line data available

Company NameYunnan Baiyao Group Co., Ltd.
Listing Date1993-12-15
Issue Price3.38RMB
Registered Capital178426.260310k RMB
Legal RepresentativeDong Ming
Registered AddressNo. 3686, Yunnan Baiyao Street, Chenggong District, Kunming City, Yunnan Province
IndustryTraditional Chinese Medicine II
Main BusinessYunnan Baiyao series products and natural botanical medicine series products
Company ProfileYunnan Baiyao Group Co., Ltd., English name: YUNNAN BAIYAO GROUP CO.,LTD. Yunnan Baiyao was created in 1902, a well-known trademark in China, listed among the first batch of national innovative enterprises, and is a time-honored Chinese brand renowned both domestically and internationally. In 1971, the factory was established under the instruction of Premier Zhou Enlai. In 1993, it became the first listed company in Yunnan on the Shenzhen Stock Exchange. In 1996, the brand achieved complete unification. In 1999, the company successfully implemented corporate reengineering. In 2005, it launched the 'Stabilize the Core, Breakthrough on Two Wings' product strategy. In 2010, it began implementing the 'New Baiyao, Great Health' industry strategy, gradually evolving from a traditional Chinese medicine enterprise into one of the leading companies in China's great health industry. In 2016, Yunnan Baiyao implemented a mixed-ownership reform at the controlling shareholder level through capital increase and share expansion, absorbing over 20 billion RMB in private capital from Xinhua Du and Jiangsu Yuyue. In April 2019, approved by the China Securities Regulatory Commission, Yunnan Baiyao Group Co., Ltd. absorbed and merged Yunnan Baiyao Holding Co., Ltd., achieving a backdoor listing. State-owned and private capital became the two major shareholders side-by-side, streamlining the system and activating the mechanism. The Baiyao mixed-ownership reform, due to its thoroughness and pioneering nature, is hailed as the 'Baiyao Model' of mixed-ownership reform.

Stock Details

1. Key Indicators

  • Total Shares(W): 178426.26
  • Circulating A-Shares(W): 177279.41
  • Earnings Per Share(RMB): 2.6800
  • Net Assets Per Share(RMB): 22.2688
  • Operating Revenue(W RMB): 3065421.42
  • Total Profit(W RMB): 561509.85
  • Net Profit Attributable to Parent(W RMB): 477711.97
  • Net Profit Growth Rate(%): 10.41
  • Weighted Return on Equity(%): 11.9200
  • Operating Cash Flow Per Share(RMB): 2.4970
  • Undistributed Profit Per Share(RMB): 9.9907
  • Capital Reserve Per Share(RMB): 9.9157

2. Main Business

The main business covers:

  • Pharmaceuticals
  • Health Products
  • Chinese Medicine Resources
  • Yunnan Provincial Pharmaceutical Company

3. Company Basic Information

  • Company Name: Yunnan Baiyao Group Co., Ltd.
  • Listing Date: 1993-12-15
  • Industry: Pharmaceutical Manufacturing
  • Address: No. 3686, Yunnan Baiyao Street, Chenggong District, Kunming City, Yunnan Province, China
  • Website: www.yunnanbaiyao.com.cn
  • Company Profile: The company's predecessor was Yunnan Baiyao Factory. In May 1993, it began its shareholding system restructuring. Part of the original factory's net assets and the initiators' investments were converted into 40 million state shares, 16 million legal person shares, and 4 million privately placed legal person shares. After the initial public offering in November of the same year, the total number of shares upon listing was 80 million. Employee shares of 1.9812 million were listed for trading on July 11, 1994.

4. Top 10 Circulating Shareholders

Rank Institution Name Institution Type Shares Held (W) Percentage Held (%)
1 Yunnan Provincial State-owned Equity Operation and Management Co., Ltd. General Legal Person 46743.18 26.37
2 New Huadu Industrial Group Co., Ltd. General Legal Person 37974.22 21.42
3 Yunnan Hehe (Group) Co., Ltd. General Legal Person 14618.59 8.25
4 Hong Kong Securities Clearing Company Ltd. Northbound Capital 6050.77 3.41
5 New Huadu Group - Guosen Securities - 25 New Huadu EB01 Guarantee and Trust Property Special Account Asset Management Plan 5600.00 3.16
6 China Securities Finance Corporation Limited Special Legal Person 3737.31 2.11
7 Central Huijin Asset Management Co., Ltd. Special Legal Person 1661.74 0.94
8 China Life Insurance Company Limited - Traditional - Ordinary Insurance Product - 005L-CT001 Hu General Legal Person 1519.86 0.86
9 Huatai-PineBridge CSI 300 Exchange Traded Open-End Index Securities Investment Fund Fund 1514.50 0.85
10 E Fund CSI 300 Healthcare Sector Exchange Traded Open-End Index Securities Investment Fund Fund 1117.68 0.63

5. Concept Sectors

  • Tongdaxin 88
  • Industrial Hemp
  • Mask Protection
  • Medical Aesthetics Concept
  • Innovative Drugs
  • Margin Trading & Securities Lending
  • Overall Listing
  • Large-Cap Stocks
  • High-Performance Stocks
  • Industry Leader
  • Being Subject to a Takeover Bid
  • China Securities Finance & Central Huijin
  • MSCI Constituent
  • Northbound Heavy Holdings
  • Non-Cyclical Stocks
  • High-Dividend Stocks
  • High Accounts Receivable
  • CSI 100 Index
  • SZSE Value Index
  • Large-Cap Value Index
  • SZSE Component Index
  • SZSE 100 Index
  • SZSE 300 Index
  • SZSE Dividend Index
  • SZSE Corporate Governance Index
  • Consumption 100 Index
  • SZSE Value Index (National)
  • CSI 300 Index
  • CCTV 50 Index
  • CSI 200 Index
  • CSI 300 Non-Cyclical Index
  • Investment Clock Index
  • CSI 300 ESG Index
  • State-Owned Enterprise Reform
  • SZSE 50 Index
  • SZSE Main Board 50 Index
  • Analyst Index
  • CSI A100 Index

Remarks

  • Data update date: 2026-01-01
  • Data source: Public Market Information